How many employees work at Medipath?

About Medipath

For more than years, MEDIPATH, led by doctors, has brought together private pathologists, carrying out activity in screening and medical diagnosis in pathological anatomy and cytology. MEDIPATH has more doctors, referring pathologists in the national networks of expertise in rare pathologies of the National Cancer Institute (INCa), molecular pathologists, spread across geographical centers, and more employees, today give it a place of leader in anatomical pathology. The company pursues a public health mission in the screening and diagnosis of cancer, collaborates with more than healthcare establishments and processes more than one and a half million cases each year: this represents % of cancer diagnostics in France. MEDIPATH is a pioneer in its quality approach in the accreditation of its technical platforms and medico-administrative sites. Its “general” and molecular pathology platforms are accredited to carry out the molecular tests necessary for targeted therapies (KRAS , BRAF. Concerned with developing ever more efficient expertise, MEDIPATH oriented itself very early on towards Artificial Intelligence. Our AI tool, Galen™ Prostate, supports pathologists in the diagnosis of prostate cancer, by offering a second reading. This innovation is a major breakthrough, powerful and highly efficient! The excellence of its technical platforms and its geographical coverage allow it to achieve a major objective of its project: “pooling for access to excellence, local expertise in patient care.